178 related articles for article (PubMed ID: 31004441)
1. Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection.
Bousman CA; Zierhut H; Müller DJ
Clin Pharmacol Ther; 2019 Aug; 106(2):309-312. PubMed ID: 31004441
[No Abstract] [Full Text] [Related]
2. "Black box" pharmacogenetic decision-support tools in psychiatry.
Bousman CA; Eyre HA
Braz J Psychiatry; 2020 Apr; 42(2):113-115. PubMed ID: 31994639
[No Abstract] [Full Text] [Related]
3. [Pharmacogenetics in daily practice].
van Gelder T; van Schaik RHN
Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32608920
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic associations and evidence-based pharmacogenomics guidelines: supporting label and off-label use of drug-gene interaction data.
Kisor DF; Monte AA; Müller DJ
Pharmacogenomics; 2020 May; 21(7):427-430. PubMed ID: 32319356
[No Abstract] [Full Text] [Related]
5. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
[TBL] [Abstract][Full Text] [Related]
6. Misleading Guidance From Pharmacogenomic Testing.
Rahman T; Ash DM; Lauriello J; Rawlani R
Am J Psychiatry; 2017 Oct; 174(10):922-924. PubMed ID: 28965468
[No Abstract] [Full Text] [Related]
7. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
McKillip RP; Borden BA; Galecki P; Ham SA; Patrick-Miller L; Hall JP; Hussain S; Danahey K; Siegler M; Sorrentino MJ; Sacro Y; Davis AM; Rubin DT; Lipstreuer K; Polonsky TS; Nanda R; Harper WR; Koyner JL; Burnet DL; Stadler WM; Ratain MJ; Meltzer DO; O'Donnell PH
Clin Pharmacol Ther; 2017 Jul; 102(1):106-114. PubMed ID: 27981566
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics: Chasing Perfection.
Gaedigk A
Clin Pharmacol Ther; 2019 Aug; 106(2):265-270. PubMed ID: 31355458
[No Abstract] [Full Text] [Related]
9. Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics-Based Patient Care Program in a Real-World Setting.
Kim RB
Clin Pharmacol Ther; 2019 Nov; 106(5):933-935. PubMed ID: 31520405
[No Abstract] [Full Text] [Related]
10. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Amstutz U; Henricks LM; Offer SM; Barbarino J; Schellens JHM; Swen JJ; Klein TE; McLeod HL; Caudle KE; Diasio RB; Schwab M
Clin Pharmacol Ther; 2018 Feb; 103(2):210-216. PubMed ID: 29152729
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
Chang DD; Eyreeuro HA; Abbott R; Coudreaut M; Baune BT; Shaman JA; Lavretsky H; Lenze EJ; Merrill DA; Singh AB; Mulsant BH; Reynolds CF; Müller DJ; Bousman C
Pharmacogenomics; 2018 Nov; 19(16):1269-1284. PubMed ID: 30422065
[TBL] [Abstract][Full Text] [Related]
12. The challenges of implementing pharmacogenomic testing in the clinic.
Moyer AM; Caraballo PJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
[TBL] [Abstract][Full Text] [Related]
13. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
[TBL] [Abstract][Full Text] [Related]
14. A stepwise approach to implementing pharmacogenetic testing in the primary care setting.
Weitzel KW; Duong BQ; Arwood MJ; Owusu-Obeng A; Abul-Husn NS; Bernhardt BA; Decker B; Denny JC; Dietrich E; Gums J; Madden EB; Pollin TI; Wu RR; Haga SB; Horowitz CR
Pharmacogenomics; 2019 Oct; 20(15):1103-1112. PubMed ID: 31588877
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models.
Hayward J; McDermott J; Qureshi N; Newman W
Pharmacogenomics; 2021 Aug; 22(12):761-776. PubMed ID: 34467776
[TBL] [Abstract][Full Text] [Related]
16. Clinical and regulatory considerations in pharmacogenetic testing.
Schuck RN; Marek E; Rogers H; Pacanowski M
Am J Health Syst Pharm; 2016 Dec; 73(23):1999-2006. PubMed ID: 27864207
[TBL] [Abstract][Full Text] [Related]
17. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
Hachad H; Ramsey LB; Scott SA
Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
[No Abstract] [Full Text] [Related]
18. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
Bousman C; Maruf AA; Müller DJ
Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
[TBL] [Abstract][Full Text] [Related]
19. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
Hafner S; Haubensak S; Paul T; Zolk O
Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
[No Abstract] [Full Text] [Related]
20. Development of Rapid Pharmacogenomic Testing Assay in a Mobile Molecular Biology Laboratory (2MoBiL).
Psarias G; Iliopoulou E; Liopetas I; Tsironi A; Spanos D; Tsikrika A; Kalafatis K; Tarousi D; Varitis G; Koromina M; Siamoglou S; Patrinos GP
OMICS; 2020 Nov; 24(11):660-666. PubMed ID: 33064577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
